Vivos Therapeutics CEO R Huntsman's 2020 pay jumps 39% to $455K
Vivos Therapeutics reports 2020 executive compensation
By ExecPay News
Published: June 29, 2021
Vivos Therapeutics reported fiscal year 2020 executive compensation information on June 29, 2021.
In 2020, three executives at Vivos Therapeutics received on average a compensation package of $341K, a 11% increase compared to previous year.
Average pay of disclosed executives at Vivos Therapeutics
R. Kirk Huntsman, Chief Executive Officer, received $455K in total, which increased by 39% compared to 2019. 55% of Huntsman's compensation, or $252K, was in salary. Huntsman also received $178K in non-equity incentive plan and $26K in other compensation.
G. Dave Singh, Chief Medical Officer, received a compensation package of $299K, which increased by 1% compared to previous year. 84% of the compensation package, or $250K, was in salary.
Bradford Amman, Chief Financial Officer, earned $269K in 2020, a 10% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on June 29, 2021.